SF3B1 and breast carcinoma: In support of the link between SF3B1 activity and AKT pathway, it has been recently reported that SF3B1K700E mutation can modulate the expression of key components of the AKT pathway with resulting increases in the migration/invasion of breast cancer cells [39].